Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brenipatide in Uncontrolled Moderate to Severe Asthma
NCT07219173Phase 2Recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2025
- Primary completion
- Apr 2028
- Modality
- Peptides
- Countries
- 12
01
Overview
A Phase 2 trial of brenipatide in asthma, sponsored by Eli Lilly and Company. Started Oct 2025; status: recruiting.
02
Drugs
brenipatide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07219173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07219173.